| __timestamp | Perrigo Company plc | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 675200000 | 10811000 |
| Thursday, January 1, 2015 | 771800000 | 33001000 |
| Friday, January 1, 2016 | 1205500000 | 64936000 |
| Sunday, January 1, 2017 | 1146500000 | 99909000 |
| Monday, January 1, 2018 | 1125800000 | 127724000 |
| Tuesday, January 1, 2019 | 1166100000 | 161524000 |
| Wednesday, January 1, 2020 | 1175500000 | 182933000 |
| Friday, January 1, 2021 | 1111400000 | 219982000 |
| Saturday, January 1, 2022 | 1210100000 | 278139000 |
| Sunday, January 1, 2023 | 1274600000 | 309799000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Ultragenyx Pharmaceutical Inc. and Perrigo Company plc from 2014 to 2023.
Perrigo Company plc, a leader in over-the-counter healthcare products, has consistently maintained higher SG&A expenses compared to Ultragenyx, a biopharmaceutical company focused on rare diseases. Over the past decade, Perrigo's SG&A expenses have grown by approximately 89%, peaking in 2023. In contrast, Ultragenyx has seen a staggering increase of over 2,700% in the same period, reflecting its aggressive expansion and investment in niche markets.
This financial trajectory highlights the contrasting business models: Perrigo's steady growth versus Ultragenyx's rapid scaling. Investors and industry analysts should consider these trends when evaluating the strategic directions of these companies.
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Ultragenyx Pharmaceutical Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Cost Management Insights: SG&A Expenses for Ultragenyx Pharmaceutical Inc. and BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited
Perrigo Company plc or MiMedx Group, Inc.: Who Manages SG&A Costs Better?